NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Celia S. Segal
Latest Publications
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
